Pharmaceutical News

RSS

Study shows use of 'the abortion pill' bounced back in Texas after FDA label change

A new Texas Policy Evaluation Project study shows that use of medication abortion, also known as "the abortion pill," bounced back in Texas after a March 2016 label change by the US Food and Drug Administration.

26 Feb 2019

New research finds how cancer cells acquire resistance to molecular-targeted drugs

Although molecular-targeted drugs have been known to show high efficacy to lung cancer patients, they also have limitations due to acquiring resistance to the drug used.

25 Feb 2019

In Florida, drug re-importation from Canada finds new champions, old snags

Florida Gov. Ron DeSantis said Wednesday he intends to bring down skyrocketing drug prices by leaning on an existing federal law that could enable the state to import prescription meds wholesale from Canada, where they're much cheaper.

25 Feb 2019

A single round of chemotherapy has no effect on sperm count, say researchers

Men with early-stage testicular can safely undergo one round of post-operative chemotherapy or radiotherapy without a long-term negative effect on sperm count.

25 Feb 2019

Big-data analysis finds new link between popular arthritis drug and heart valve calcification

A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification - commonly called NSAIDs.

23 Feb 2019

U.S.-based patient advocacy organizations received majority of pharma donations, finds study

A new study by Johns Hopkins Bloomberg School of Public Health researchers found that U.S.-based patient advocacy organizations received a disproportionate amount of contributions made by the world's 10 largest pharmaceutical companies in 2016.

23 Feb 2019

Researchers develop highly sensitive cell model to study complex effects of anti-inflammatory drugs

Drugs such as ibuprofen or aspirin that relieve pain and lower fever are among the most frequently used drugs worldwide. They are used above all for the treatment of inflammatory reactions. However, in spite of their indisputable effectiveness and frequent use, we do not yet fully understand the underlying mechanisms of these drugs.

23 Feb 2019

'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease

Yerba santa, also known as the ‘Holy Herb’, may have important implications for patients with Alzheimer’s disease.

22 Feb 2019

Besides the U.S., drug overdose mortality is also common in other high-income countries

Is the current American drug overdose epidemic an isolated phenomenon? Have other high-income countries experienced similar increases in drug overdose mortality, or are they likely to going forward? A new study published in Population and Development Review addresses these questions.

21 Feb 2019

A holistic approach key to minimize treatment complexity in patients with interstitial lung disease

Patients with interstitial lung disease—a group of disorders causing progressive scarring of lung tissue—are often prescribed various medications that specifically target their disease and others that treat their symptoms.

21 Feb 2019

Saffron may be a promising herbal alternative for treating ADHD

A new short-term pilot study in children and teens 6-17 years old with attention-deficit hyperactivity disorder has shown saffron to be as effective at controlling symptoms as methylphenidate, the commonly prescribed drug Ritalin.

21 Feb 2019

Cervical cancer could be eradicated by 2100

Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.

21 Feb 2019

Researchers discover a new promising target to improve HIV vaccines

In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus's outer envelope where a lineage of antibodies are able to dock and neutralize the virus.

21 Feb 2019

Some drug combinations may be more effective than others for schizophrenic patients

Patients with schizophrenia are often treated with more than one type of psychiatric medication, but a new study suggests that some combinations may be more effective than others.

21 Feb 2019

Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness

More than 70,000 Australians who suffer from chronic breathlessness will now have access to life-changing medication to manage their symptoms.

19 Feb 2019

Common acid reflux drugs tied to elevated risk for kidney disease

Proton pump inhibitors, which include well-known brand names Prilosec, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease.

19 Feb 2019

Drug combinations could become first-line treatment for metastatic kidney cancer

A combination of two drugs - one of them an immunotherapy agent - could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

18 Feb 2019

Cholesterol-lowering drugs could help prevent onset of motor neurone disease

High cholesterol has been found to be a possible risk factor for the development of motor neurone disease, according to a large study of genetic data led in the UK by Queen Mary University of London, in collaboration with the National Institutes of Health in the USA.

14 Feb 2019

Antidepressant drug could save people from deadly sepsis, research suggests

An antidepressant drug used to treat obsessive-compulsive disorder could save people from deadly sepsis, new research from the University of Virginia School of Medicine suggests.

14 Feb 2019

Study finds no association between antiepileptic drug use and dementia risk

Epilepsy is a common neurological condition with a prevalence of around 2%. Many antiepileptic drugs are available to prevent epileptic seizures, allowing up to 80 percent of patients to become seizure-free.

13 Feb 2019

Pharmaceutical News

Study shows use of 'the abortion pill' bounced back in Texas after FDA label change

New research finds how cancer cells acquire resistance to molecular-targeted drugs

In Florida, drug re-importation from Canada finds new champions, old snags

A single round of chemotherapy has no effect on sperm count, say researchers

Big-data analysis finds new link between popular arthritis drug and heart valve calcification

U.S.-based patient advocacy organizations received majority of pharma donations, finds study

Researchers develop highly sensitive cell model to study complex effects of anti-inflammatory drugs

'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease

Besides the U.S., drug overdose mortality is also common in other high-income countries

A holistic approach key to minimize treatment complexity in patients with interstitial lung disease

Saffron may be a promising herbal alternative for treating ADHD

Cervical cancer could be eradicated by 2100

Researchers discover a new promising target to improve HIV vaccines

Some drug combinations may be more effective than others for schizophrenic patients

Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness

Common acid reflux drugs tied to elevated risk for kidney disease

Drug combinations could become first-line treatment for metastatic kidney cancer

Cholesterol-lowering drugs could help prevent onset of motor neurone disease

Antidepressant drug could save people from deadly sepsis, research suggests

Study finds no association between antiepileptic drug use and dementia risk

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News